Seasonal influenza vaccines 2012
6 February 2012
Influenza vaccines can change from year to year as new strains of influenza virus appear. There has been no evidence of the emergence of a new strain and, therefore, the Australian Influenza Vaccine Committee (AIVC) has recommended no change to the composition of influenza vaccines for Australia from 2011 to 2012.
For the 2012 influenza season, the TGA has registered 6 vaccines for use in the following age groups:
| Vaccine | Sponsor | Age group |
|---|---|---|
| Agrippal | Novartis | 6 months and over |
| Fluarix | GSK | 6 months and over |
| Influvac* | Abbott | 6 months and over |
| Vaxigrip* | Sanofi Pasteur | 6 months and over |
| Fluvax** | CSL | 5 years and over** |
| Intanza | Sanofi Pasteur | 18-59 years |
* These vaccines also have a paediatric ("Junior") presentation registered for use in children aged 6 to 35 months
** Febrile events have been observed in children aged 5 to 9 years following immunisation with Fluvax. Therefore, in this age group, a decision to vaccinate with the 2012 Fluvax vaccine should be based on careful consideration of potential benefits and risks in the individual.
For further information on individual vaccines, please refer to the relevant Product Information document.
Content last updated: Monday, 6 February 2012
Content last reviewed: Monday, 6 February 2012
Web page last updated: Monday, 14 January 2013
URL: http://www.tga.gov.au/newsroom/media-2012-seasonal-flu-120206.htm